Shockwave Medical Inc (SWAV) Inventory Turnover Ratio, from first quarter 2024 to first quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Shockwave Medical Inc   (NASDAQ: SWAV)
 

Shockwave Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Shockwave Medical Inc 's Inventory turnover ratio has remained unchanged compare to previous quarter at 1 in the first quarter 2024Average processing period, for Shockwave Medical Inc 's inventories remained unchanged at 365 days, in the Mar 31 2024 quarter.

Within Healthcare sector 340 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 965 in the fourth quarter 2023, to 1265.

SWAV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Shockwave Medical Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SWAV Inventory Turnover Ratio (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Inventory Growth 33.58 % 43.24 % 40.89 % 53.42 % 56 %
Y / Y Cost of Sales Growth 32.92 % 48.18 % 34.27 % 43.45 % 63.43 %
Inventory Turnover Ratio (TTM) 1 1 1 1.01 1.02
SWAV's Total Ranking # 1265 # 965 # 783 # 1405 # 1405
Average inventory processing period 365 365 366 362 358
Seq. Inventory Growth 3.37 % 10.71 % 5.52 % 10.61 % 10.84 %
Seq. Cost of Sales Growth 7.97 % 8.06 % 0 % 13.93 % 20.36 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 154
Healthcare Sector # 341
Overall Market # 1265

Inventory Turnover Ratio Statistics
High Average Low
1.87 1.06 0.08
(Dec 31 2019)  



SWAV Company Profile >> Back to SWAV Efficiency Comparisons >> Compare SWAV Inventory Turnover Ratio to its Competitors

Financial Statements
Shockwave Medical Inc 's Inventories $ 111 Millions Visit SWAV's Balance sheet
Shockwave Medical Inc 's Cost of Revenues TTM $ 102 Millions Visit SWAV's Income Statement
What are SWAV's Sales? Visit SWAV's Sales by Segment

Other Inventory Turnover Ratios
Shockwave Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SWAV's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SWAV's Competitors
Inventory Turnover Ratio for SWAV's Suppliers
Inventory Turnover Ratio for SWAV's Customers

You may also want to know
SWAV's Sales Growth Rates SWAV's Pe Price to earnings ratio SWAV's Receivables Turnover Ratio SWAV's Stock Quote
SWAV's Net Income Growth Rates SWAV's Ps Price to Sales ratio SWAV's Sales per Employee SWAV's Asset Turnover Ratio
SWAV's Net Margin SWAV's Pb Price to Book ratio SWAV's Financial Strength Ratios SWAV's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2024 Inventories at quarter ending Mar 31 2024
International Stem Cell Corporation  2.52 $ 3.244  Millions$ 1  Millions
Standard Biotools Inc   2.51 $ 65.797  Millions$ 26  Millions
Cutera Inc   2.50 $ 164.000  Millions$ 66  Millions
China Pharma Holdings Inc  2.50 $ 7.170  Millions$ 3  Millions
Phibro Animal Health Corporation  2.49 $ 694.731  Millions$ 279  Millions
Biolase Inc   2.48 $ 30.870  Millions$ 12  Millions
Embecta Corp   2.47 $ 387.800  Millions$ 157  Millions
Journey Medical Corp  2.46 $ 27.027  Millions$ 11  Millions
Guardion Health Sciences Inc   2.46 $ 6.000  Millions$ 2  Millions
Viatris Inc   2.45 $ 8,960.800  Millions$ 3,652  Millions
Livanova Plc  2.45 $ 379.665  Millions$ 155  Millions
Dariohealth Corp   2.45 $ 13.102  Millions$ 5  Millions
Biomerica Inc   2.42 $ 4.788  Millions$ 2  Millions
Celularity Inc   2.39 $ 12.013  Millions$ 5  Millions
Aytu Biopharma Inc  2.38 $ 30.401  Millions$ 13  Millions
Revvity Inc  2.31 $ 990.451  Millions$ 429  Millions
Pro dex Inc   2.31 $ 35.637  Millions$ 15  Millions
Ocular Therapeutix Inc   2.31 $ 5.393  Millions$ 2  Millions
Clene Inc   2.30 $ 0.132  Millions$ 0  Millions
Eyepoint Inc   2.28 $ 3.753  Millions$ 2  Millions
Intelligent Bio Solutions Inc   2.28 $ 2.167  Millions$ 1  Millions
10x Genomics Inc   2.28 $ 188.000  Millions$ 83  Millions
Telesis Bio Inc   2.27 $ 9.000  Millions$ 4  Millions
Marizyme Inc   2.27 $ 0.158  Millions$ 0  Millions
Alpha Teknova Inc   2.27 $ 26.302  Millions$ 12  Millions
Neuronetics Inc   2.26 $ 18.856  Millions$ 8  Millions
Edap Tms Sa  2.26 $ 40.333  Millions$ 18  Millions
Pfizer Inc  2.25 $ 23,447.000  Millions$ 10,399  Millions
Merit Medical Systems Inc  2.25 $ 685.655  Millions$ 304  Millions
Enzo Biochem Inc  2.24 $ 17.154  Millions$ 8  Millions

Date modified: 2026-08-29T17:40:56+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.